1. Targeting of MEK in lung cancer therapeutics
   David F Heigener et al, 2015, The Lancet Respiratory Medicine CrossRef
2. Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients
   Mi-Sook Lee et al, 2017, Cancer Research and Treatment CrossRef
3. Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing
   Charles Ricordel et al, 2018, Clinical Lung Cancer CrossRef
4. Large cell carcinoma of the lung: A tumor in search of an author. A clinically oriented critical reappraisal
   Giuseppe Pelosi et al, 2015, Lung Cancer CrossRef
5. Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology
   Habib Zarredar et al, 2018, Cancer Investigation CrossRef
6. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes
   Jarushka Naidoo et al, 2016, Clinical Lung Cancer CrossRef
7. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients
   Zahra Fathi et al, 2018, PLOS ONE CrossRef